Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

2021150 citationsJournal Articlegold Open Access

Authors

Low-HER2 expression did not have any impact on prognosis of metastatic breast cancer in this real-world population.

Good health and well-being

Published in: Breast Cancer Research

Volume 23, Issue 1, pp. 112-112

Field-Weighted Citation Impact: 11.36